TCM
NITE

Tekla Capital Management’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Tekla Capital Management’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-98,929
Closed -$1.14M – 208
2018
Q4 		$1.14M Sell
98,929
-51,071
-34% -$680K 0.05% 159
2018
Q3 		$3.06M Buy
+150,000
New +$3.08M 0.11% 121

Other funds holding NITE

TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Tekla Capital Management's NITE Position: Q1 2019 in Review

Tekla Capital Management sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2019, closing a stake of 98,929 shares — an estimated $1.14M sold.

Tekla Capital Management first reported a position in NITE in Q3 2018 and held it in 2 quarters. The position peaked at $3.06M in Q3 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.

  • Tekla Capital Management reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Tekla Capital Management sold 98,929 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $1.14M.
  • Tekla Capital Management first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2018 and held it in 2 quarters.
  • Tekla Capital Management's Nightstar Therapeutics plc American Depositary Shares position peaked at $3.06M in Q3 2018.
  • 53 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Tekla Capital Management's 13F filing for Q1 2019, filed 14 May 2019.